Infection Prevalence and Antibiotic Resistance Levels in Ureaplasma urealyticum and Mycoplasma hominis in Gynecological Outpatients of a Tertiary Hospital in China from 2015 to 2018

Table 4

Antibiotic resistance of U. urealyticum and M. hominis from 2015 to 2018.

Antibiotic	2015–2018	2015	2016	2017	2018	χ^2
Tetracycline	77 (2.40)	12 (1.78)	14 (1.99)	24 (2.80)	27 (2.78)	2.786	0.426
Ofloxacin	1982 (61.84)	247 (36.70)	388 (55.11)	593 (69.11)	754 (77.73)	316.8	<0.001
Doxycycline	51 (1.59)	12 (1.78)	7 (0.99)	13 (1.52)	19 (1.96)	2.628	0.453
Josamycin	32 (1.00)	6 (0.89)	4 (0.57)	10 (1.17)	12 (1.24)	2.198	0.532
Sparfloxacin	1652 (51.54)	228 (33.88)	364 (51.70)	514 (59.91)	545 (56.19)	116.5	<0.001
Roxithromycin	510 (15.91)	57 (8.47)	84 (11.93)	172 (20.05)	197 (20.31)	61.17	<0.001
Minocycline	48 (1.50)	9 (1.34)	9 (1.28)	15 (1.75)	15 (1.55)	0.728	0.867
Levofloxacin	1298 (40.50)	108 (16.05)	189 (26.85)	420 (48.95)	581 (59.90)	398.3	<0.001
Clarithromycin	401 (12.51)	48 (7.13)	69 (9.80)	144 (16.78)	140 (14.43)	40.09	<0.001
Azithromycin	454 (14.17)	49 (7.28)	75 (10.65)	160 (18.65)	169 (17.42)	56.12	<0.001